LIVE VIEW · GLUEMonte Rosa Therapeutics, Inc.BiotechnologyGLUE research Sign up to open the full interactive terminal, save boards, and get alerts
GLUE · Live chart
Loading live chart
GLUE · Smart-money compositeas of Aug 14
+9NEUTRALsmart-money positioning
-100 short0+100 long
Insiderno insider cluster in the l...
Congressno congressional trade in t...
13F fundsLONG
Short volumeFINRA short-volume is not c...
1 of 4 families contributing
GLUE · Recent signals
Q2-2026: Missed consensus by 9.6%, EPS $-0.43 vs $-0.3924 estimateMEDIUMSHORTAug 9
Q2-2025: Beat consensus by 61.9% - EPS $-0.15 vs $-0.3934 estimateMEDIUMLONGMay 29
Q3-2025: Beat consensus by 13.2% - EPS $-0.33 vs $-0.3802 estimateMEDIUMLONGMay 29
Q1-2026: Missed consensus by 16.1% - EPS $-0.45 vs $-0.3876 estimateMEDIUMSHORTMay 29
Q4-2025: Missed consensus by 56.2% - EPS $-0.56 vs $-0.3586 estimateMEDIUMSHORTMay 29
GLUE · Institutional holdersas of 2026Q1
RENAISSANCE TECHNOLOGIES LLC$6.2Mn/a
MILLENNIUM MANAGEMENT LLC$3.3Mn/a
MILLENNIUM MANAGEMENT LLC$3.1M+84.1%
RENAISSANCE TECHNOLOGIES LLC$2.9Mn/a
MILLENNIUM MANAGEMENT LLC$1.6M-76.6%
D. E. Shaw & Co., Inc.$1.3M+70.3%
TWO SIGMA INVESTMENTS, LP$1.2Mn/a
D. E. Shaw & Co., Inc.$1.1M-22.4%
Live alerts on GLUE
Live alerts on GLUEGet pinged the moment insiders, congress, or 13F funds move on GLUE.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for GLUE.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock